ABSTRACT
The COVID-19 pandemic has resulted in a significant backlog of hip and knee replacement surgeries in the United Kingdom (UK). 1,2 To address this, surgical hubs have been proposed to enhance efficiency, particularly for high-volume, low-complexity cases. 3,4 These hubs and Ambulatory Surgery Centres often lack higher level care support such as intensive care facilities and are thus suited to patients with less co-morbidity and systemic illness. Pre-operative risk assessment is required to enable correct patient allocation to the appropriate site and reduce unwarranted risk.
This study explores the use of artificial intelligence (AI) for risk stratification in hip and knee arthroplasty. A polynomial regression model was developed using patient demographics, blood results, and comorbidities to assign risk scores for postoperative complications. The model was generated from 29,658 patient records from two UK National Health Service (NHS) healthcare organisations. It demonstrated an area under the receiver operating characteristic curve (AUROC) as the evaluation metric and was capable of categorising patients into high and low risk. Validation was performed using a retrospective analysis of 445 patients. Predicted versus actual complications and need for further care were used to examine agreement. The model’s sensitivity was 70% for identifying high-risk patients and had a negative predictive value of 96%. This AI risk prediction was comparable to consultant-led care in risk stratification.
These findings suggest that AI can support more streamlined and efficient preoperative risk stratification, potentially reducing the burden on preoperative assessment teams and optimising resource allocation. While not without limitations, the AI model offers a sophisticated adjunct to clinical decision-making around determining risk. This can support facilities like hubs in the UK NHS or Ambulatory Surgery Centres in the United States.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partly funded by a Welsh Assembly Government Transformation Grant towards the OWL-I (Orthopaedic Waiting List Initiative) at the Swansea University Health Board. We are grateful for the support provided by the Digital Informatics and Information Technology departments in Swansea and Northumbria, as well as the waiting list management teams in both organisations
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Deputy Caldicott Guardian of the Swansea Bay University Health Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
